Suppr超能文献

缓激肽参与麻醉大鼠化学诱导膀胱炎的证据。

Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats.

作者信息

Maggi C A, Santicioli P, Del Bianco E, Lecci A, Guliani S

机构信息

Pharmacology Department, A. Menarini Pharmaceuticals, Florence, Italy.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):432-7. doi: 10.1007/BF00165395.

Abstract

The effect of Hoe 140, a potent bradykinin B2 receptor antagonist, on the micturition reflex and detrusor hyperreflexia induced by chemical cystitis has been investigated in anaesthetized rats. Hoe 140 (1-100 nmol/kg i.v.) produced a dose-dependent blockade of the contraction of the rat urinary bladder induced by i.v. administration of bradykinin (100 nmol/kg) without affecting the response produced by the selective tachykinin NK-1 receptor agonist, [Sar9] substance P (SP) sulfone (1 nmol/kg i.v.). At doses which produce selective and long-lasting blockade of bradykinin receptors in the urinary bladder, Hoe 140 did not modify urodynamic parameters in normal rats. Intravesical instillation of xylene in female rats decreased bladder capacity and increased micturition frequency. These effects also occurred in rats pretreated with capsaicin as adults. Hoe 140 did not modify xylene-induced cystitis. Intraperitoneal administration of cyclophosphamide (150 mg/kg, 48 h before) decreased bladder capacity and increased micturition frequency. These effects of cyclophosphamide were abolished in rats pretreated with capsaicin as adults. Hoe 140 increased bladder capacity and decreased micturition frequency in rats pretreated with cyclophosphamide. Addition of bradykinin (10 mumol/l) to the medium in the superfused rat urinary bladder preparation evoked a prompt increase in the outflow of calcitonin gene-related peptide like immunoreactivity (CGRP-LI). Hoe 140 (3 mumol/l) inhibited (by about 50%) the CGRP-LI out-flow stimulated by bradykinin. These findings demonstrate the participation of bradykinin, through B2 receptors, in the genesis of detrusor hyperreflexia during cyclophosphamide-induced cystitis.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在麻醉大鼠中,研究了强效缓激肽B2受体拮抗剂Hoe 140对化学性膀胱炎诱导的排尿反射和逼尿肌反射亢进的影响。静脉注射Hoe 140(1 - 100 nmol/kg)可剂量依赖性地阻断静脉注射缓激肽(100 nmol/kg)诱导的大鼠膀胱收缩,而不影响选择性速激肽NK - 1受体激动剂[Sar9]P物质(SP)砜(静脉注射1 nmol/kg)产生的反应。在能产生膀胱中缓激肽受体选择性和持久阻断的剂量下,Hoe 140未改变正常大鼠的尿动力学参数。在雌性大鼠膀胱内灌注二甲苯会降低膀胱容量并增加排尿频率。成年后用辣椒素预处理的大鼠也会出现这些效应。Hoe 140未改变二甲苯诱导的膀胱炎。腹腔注射环磷酰胺(150 mg/kg,提前48小时)会降低膀胱容量并增加排尿频率。成年后用辣椒素预处理的大鼠可消除环磷酰胺的这些效应。Hoe 140可增加环磷酰胺预处理大鼠的膀胱容量并降低排尿频率。向灌流的大鼠膀胱制备物的培养基中添加缓激肽(10 μmol/l)可迅速增加降钙素基因相关肽样免疫反应性(CGRP - LI)的流出量。Hoe 140(3 μmol/l)可抑制(约50%)缓激肽刺激的CGRP - LI流出。这些发现表明缓激肽通过B2受体参与环磷酰胺诱导的膀胱炎期间逼尿肌反射亢进的发生。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验